Proposal for Levels of Evidence Schema for Validation of a Soluble Biomarker Reflecting Damage Endpoints in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis, and Recommendations for Study Design

W.P. Maksymowych, O. Fitzgerald, G.A. Wells, D.D. Gladman, RB Landewe, M Ostergaard, W.R. Taylor, R.B. Christensen, PP Tak, M. Boers, S.W. Syversen, J.M. Bathon, C.J. Ritchlin, P. Mease, V.P. Bykerk, P. Garnero, PP Geusens, H. El-Gabalawy, D. Aletaha, R.D. InmanV.B. Kraus, TH Kvien, D.M. Van der Heijde

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1792-1799
JournalJournal of Rheumatology
Volume36
Issue number8
DOIs
Publication statusPublished - 2009

Cite this